跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACCEL-CANDESARTAN/HCTZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACCEL-CANDESARTAN/HCTZ
Authorized
STANDARD
ACCEL-CANDESARTAN/HCTZ
accel pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cd5101000aab8512
Company
accel pharma inc
Type
Standard
Approval Details
Approval Id
cd5101000aab8512
Drug Approval Canada Name
ACCEL-CANDESARTAN/HCTZ
Product Name
ACCEL-CANDESARTAN/HCTZ
Status
Cancelled Post Market
Status Date
2020-03-05
Original Market Date
2017-12-27
Din
02463857
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09DA06 CANDERSARTAN AND DIURETICS
Atc Name
c 09 da 06
Aig Number
0244181003
Company Name
accel pharma inc
Company Address
119 Labrosse Ave, Pointe Claire, Quebec, Canada, H9R 1A3
Active Ingredients
HYDROCHLOROTHIAZIDE
25 MG
CANDESARTAN CILEXETIL
32 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cd5101000aab8512
Type
Standard
Back to Health Canada Approvals